Democritus University of Thrace (DUTH)
Το τρανεξαμικό στην ολική αρθροπλαστική του γόνατος
Abstract
dc:descriptionUse of tranexamic acid (TXA) is effective and safe in reducing the blood loss in total knee replacement (TKR) performed using a tourniquet, but data in TKR performed without tourniquet is limited and there is no study comparing the topical (T) to intravenous (IV) TXA administration. Furthermore, there are no data in favour or against multiple TXA dosage administration. Our first study's aim was to compare the topical (T) to intravenous (IV) TXA administration in TKR performed without tourniquet. Second study will compare the results between three different IV TXA regimens. Material and methods (First RCT): 120 patients undergoing unilateral TKR for knee osteoarthritis were included in a prospective randomised study. Operations were performed under spinal anaesthesia, no tourniquet was used and the post-operative regime was the same for all patients. Patients were divided in 3 groups; in Group C (control) (n:40) received no TXA, in Group IV (n:40) received 1 gr TXA intra-venously and in Group L (n:40) 1 gr TXA was applied locally. The primary outcome measures included the calculated blood loss, the transfusion rate and quantity of allogeneic blood units while secondary outcome measures were complications.Results (First RCT): There was no statistically significant difference in patient’s demographics and perioperative results. Calculated blood loss, allogeneic blood transfusion rate and quantity in Group C were significantly higher compared to TXA Groups (p<0.001). There was no significant difference in complications rate between the three groups.Conclusions (First RCT): According to the results of this study, IV or T administration of 1 gr of TXA significantly reduced the blood loss and the need for allogeneic blood transfusion (ABT) in patients undergoing TKR without a tourniquet (with no significant difference between the two routes of administration).Materials and methods (Second RCT): A total of 180 patients undergoing TKA for knee osteoarthritis were stratified in three equal groups. All surgeries were performed under spinal anesthesia, without tourniquet. Group A (60 patients) received 15 mg/kg of IV TXA given on induction, Group B (60 patients) received an additional dose of IV TXA (15 mg/kg) 3 h after incision and Group C (60 patients) received an additional (third) dose 3 h later (15 mg/kg). The measured outcomes were the change in hemoglobin (Hb) from pre-operatively to post-operatively, the amount of blood transfusion given (units), the functional and quality of life (QoL) and pain assessment based on their corresponding scoring system. Results (Second RCT): Calculated blood loss, Hb decrease and transfusion rate were significantly lower in Group C (p value < 0.05). Addi- tionally, patients that had been included in the three-dosage group benefited much more in terms of faster rehabilitation, better QoL, decreased post-operative pain, with no increase in complications.Conclusion (Second RCT): According to our results, three doses of IV TXA have effectively and safely reduced blood loss and the need of allogeneic blood transfusion in patients undergoing TKA without tourniquet, with additional patients-related benefits.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tzatzairis, Themistoklis
- Τζατζαΐρης, Θεμιστοκλής
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45931